Ursula Rommerscheidt‐Fuss

<scp>NOTCH</scp>, <scp>ASCL1</scp>, p53 and <scp>RB</scp> alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas

Lydia Meder, Katharina König, Luka Ozretić et al. · International Journal of Cancer · 2015 · 177 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

Katharina König, Martin Peifer, Jana Fassunke et al. · Journal of Thoracic Oncology · 2015 · 94 citations · Full text

Medicine, Molecular Biology, Oncology +14

Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer

Michael Kloth, Vanessa Ruesseler, Christoph Engel et al. · Gut · 2015 · 74 citations

Medicine, Molecular Biology, Molecular Genetics +17

Four-and-a-Half LIM Domain Protein 2 Is a Novel Regulator of Sphingosine 1-Phosphate Receptor 1 in CCL19-Induced Dendritic Cell Migration

Katharina König, Linda Diehl, Ursula Rommerscheidt‐Fuss et al. · The Journal of Immunology · 2010 · 39 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Loss of the Keratin Cytoskeleton Is Not Sufficient to Induce Epithelial Mesenchymal Transition in a Novel KRAS Driven Sporadic Lung Cancer Mouse Model

Katharina König, Lydia Meder, Cornelia Kröger et al. · PLoS ONE · 2013 · 28 citations · Full text

Medicine, Molecular Biology, Oncology +16